India's first indigenously developed vaccine against the H5N1 bird flu virus in chickens will be dedicated to the nation on November 20 at the ICAR-National Institute of High Security Animal Diseases (ICAR-NIHSAD) in Bhopal, according to an official statement issued on Wednesday and reported by IANS.

Source: IANS

Union Agriculture and Farmers Welfare Minister Shivraj Singh Chouhan will dedicate the 'Inactivated H5N1' vaccine to the nation at ICAR-NIHSAD, Bhopal, the Press Information Bureau (PIB) said in its release.

The vaccine targets the H5N1 virus of Clade 2.3.2.1a, the strain responsible for most bird flu outbreaks in chickens in India. At present, no specific commercial vaccine is available against this clade, the official statement said.

Why this vaccine matters

Highly pathogenic avian influenza has repeatedly hit India's poultry sector. NationPress reported that India has recorded more than 500 outbreaks of H5N1 and H5N8 avian influenza since 2006, with heavy losses for poultry farmers — the gap this home-grown vaccine is meant to close.

Source: NationPress

ICAR-NIHSAD, Bhopal, is one of India's premier high-security animal-disease research institutes under the Indian Council of Agricultural Research (ICAR). The November 20 dedication is expected to mark the vaccine's move from development toward rollout planning for poultry disease control.

At a glance

Vaccine: Inactivated H5N1 (Clade 2.3.2.1a) for chickens · Developer: ICAR-NIHSAD, Bhopal · Dedicated to the nation: November 20, 2026, by Agriculture Minister Shivraj Singh Chouhan.